MSH2 and endometrial cancer: Although about one-third of females with an MLH1 epimutation developed endometrial cancer, and one case with an EPCAM deletion linked to MSH2 epimutation also developed endometrial cancer [12,20], constitutional methylation of the MMR genes has not previously been studied in an unselected series of endometrial cancer cases.